The Role of the Microbiome and Intestinal Mucosal Barrier in the Development and Progression of Non-Alcoholic Fatty Liver Disease

Por T. S. Krolevets, M. A. Livzan, S. I. Mozgovoy
Publicado em 2020-12-01

Neuroendocrine Tumour as a Diagnostic and Prognostic Criterion for Autoimmune Gastritis

Por S. I. Mozgovoi, M. A. Livzan, T. S. Krolevets, A. G. Shimanskaya
Publicado em 2020-01-01

Cardiovascular Diseases and Non-Alcoholic Fatty Liver Disease: Relationship and Pathogenetic Aspects of Pharmacotherapy

Por A. V. Nelidova, M. A. Livzan, N. A. Nikolaev, T. S. Krolevets
Publicado em 2022-01-01

Leptin resistance in patients with nonalcoholic fatty liver disease associated with obesity and overweight

Por M. A. Livzan, I. V. Lapteva, T. S. Krolevets, N. A. Cherkaschenko
Publicado em 2015-12-01

Specific features of gastroesophageal reflux disease associated with obesity and overweight

Por M A Livzan, I V Lapteva, T S Krolevets, I E Kiselev
Publicado em 2016-02-01

Adherence to lifestyle modification in patients with nonalcoholic fatty liver disease

Por K. A. Andreev, Yu. P. Skirdenko, N. A. Nikolaev, M. A. Livzan, A. V. Gorbenko, M. M. Fedorin, T. S. Krolevets
Publicado em 2022-01-01

Circulating levels of proinflammatory mediators as potential biomarkers of post-traumatic knee osteoarthritis development

Por Panina, Svetlana B., Krolevets, Igor V., Milyutina, Natalia P., Sagakyants, Alexander B., Kornienko, Igor V., Ananyan, Anzhelika A., Zabrodin, Mikhail A., Plotnikov, Andrey A., Vnukov, Valeriy V.
Publicado no J Orthop Traumatol (2017)